Your browser doesn't support javascript.
loading
Prognostic Impact of Urokinase Plasminogen Activator Receptor Expression in Pancreatic Cancer: Malignant Versus Stromal Cells.
de Geus, Susanna Wl; Baart, Victor M; Boonstra, Martin C; Kuppen, Peter Jk; Prevoo, Hendrica Ajm; Mazar, Andrew P; Bonsing, Bert A; Morreau, Hans; van de Velde, Cornelis Jh; Vahrmeijer, Alexander L; Sier, Cornelis Fm.
Afiliación
  • de Geus SW; Department of Surgery, Leiden University Medical Centre, Leiden, The Netherlands.
  • Baart VM; Department of Surgery, Leiden University Medical Centre, Leiden, The Netherlands.
  • Boonstra MC; Department of Surgery, Leiden University Medical Centre, Leiden, The Netherlands.
  • Kuppen PJ; Department of Surgery, Leiden University Medical Centre, Leiden, The Netherlands.
  • Prevoo HA; Department of Surgery, Leiden University Medical Centre, Leiden, The Netherlands.
  • Mazar AP; Monopar Therapeutics Inc., Northbrook, IL, USA.
  • Bonsing BA; Department of Surgery, Leiden University Medical Centre, Leiden, The Netherlands.
  • Morreau H; Department of Pathology, Leiden University Medical Centre, Leiden, The Netherlands.
  • van de Velde CJ; Department of Surgery, Leiden University Medical Centre, Leiden, The Netherlands.
  • Vahrmeijer AL; Department of Surgery, Leiden University Medical Centre, Leiden, The Netherlands.
  • Sier CF; Department of Surgery, Leiden University Medical Centre, Leiden, The Netherlands.
Biomark Insights ; 12: 1177271917715443, 2017.
Article en En | MEDLINE | ID: mdl-28690396

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Biomark Insights Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Biomark Insights Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos